Liquid allows immediate research use without preparation
In what the White House is calling a historic step to lower drug costs, President Donald Trump announced new agreements with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to slash prices and expand coverage of GLP-1 medications, including Ozempic, Wegovy, Zepbound, and Mounjaro
In December 2025, Eli Lilly published the first positive Phase 3 readout for retatrutide (LY3437943), the triple-agonist peptide that had, until then, only been validated at Phase 2 scale
Sometimes infertility is caused by other factors, such as blocked tubes, fibroids, low sperm count, etc
Weight loss continues at the lower dose, albeit at a slower rate, and the metabolic health improvements accumulated during the higher-dose phase persist as long as the protocol continues
Patient Factors Who benefits the most from clinically significant fat loss results the ones that matter and stick